Objectives: This study aimed to clarify the short-term symptoms, duration, and influencing factors in people recovering from coronavirus disease (COVID-19) after China’s dynamic zero-COVID-19 policy was implemented in December, 2022. Methods: We included data from a large-scale online survey conducted in China between January 14 and February 1, 2023. Participants were individuals of all ages. Chi-squared tests and multivariate logistic regression analyses were performed to identify factors associated with different symptoms. Results: Overall, 21,012 patients from seven regions of China were included in this study (female: 71.22%). For most patients, the period from symptom onset to a negative nucleic acid test result was ≤10 days (72.33%). The distribution of symptoms varied at different times, with respiratory (1–4 weeks) and psycho-cardiology (5–8 weeks) symptoms being the most common. Multivariate analysis identified male sex, no comorbidity, and living in northeast and northwest China (compared with central China) as independent factors associated with lower risk of symptoms, while age (41–60 years) was a possible risk factor (compared with 18–40 years). Conclusions: Short-term respiratory and psycho-cardiology symptoms were the most common after COVID-19 recovery. Sex, age, geographical region, and comorbidities were potential influencing factors for the development of short-term symptoms. Graphical abstract: http://links.lww.com/AHM/A183
Cao et al. (Tue,) studied this question.